Health

Vaccine Market Size Worth USD 77.90 Billion in 2028

Emergen Research Logo

Market Size – USD 44.82 Billion in 2020, Market Growth – at a CAGR of 7.1%

Rise in prevalence of infectious diseases and increased investment in vaccine development activities are some key factors driving market revenue growth”

— Emergen Research

VANCOUER, BC, CANADA, June 16, 2022 /EINPresswire.com/ — The global vaccine market size is expected to reach USD 77.90 Billion at a steady revenue CAGR of 7.1% in 2028, according to latest analysis by Emergen Research. An increase in prevalence of infectious diseases is a key factor driving global vaccine market revenue growth.

The report is formulated through extensive primary and secondary research and is curated with an intent to offer the readers and businesses a competitive edge over other players in the industry. The report sheds light on the minute details of the Vaccine industry pertaining to growth factors, opportunities and lucrative business prospects, regions showing promising growth, and forecast estimation till 2028.

Get Free Sample PDF @

Furthermore, the report provides a comprehensive analysis of the factors that are likely to bolster or impede the growth of the market in the coming years. The report considers the COVID-19 pandemic that is currently unfolding as a key market influencer. The report provides a thorough estimation of the overall impact of the pandemic on the Vaccine market and its vital segments. The report also discusses the impact of the pandemic across different regions of the market. It also offers a current and future assessment of the impact of the pandemic on the Vaccine market.

Some Key Highlights from the Report

In August 2021, Pfizer and BioNTech announced a collaboration with Brazil’s Eurofarma to manufacture COVID-19 vaccine doses for Latin American countries. COMIRNATY will be manufactured by Eurofarma with Pfizer’s and BioNTech’s COVID-19 vaccine manufacturing and supply chain network. Eurofarma will get raw materials for the drug from the U.S. and manufacturing will begin in 2022. Vaccine production is expected to exceed 100 million finished doses yearly which will be exclusively distributed within Latin America.
Monovalent vaccine segment revenue is expected to register a significant growth rate during the forecast period. A monovalent vaccine is designed to immunize single microorganism and antigen (for example, measles vaccine). This type of vaccine is preferable for development of a strong immune response.
Toxoid vaccines are administered to adults as well as children to protect them against tetanus and diphtheria. This vaccine is administered to induce an immune response to protect against disease caused by toxins secreted by specific bacteria. This vaccine is part of a course of multiple doses and booster shots are given when travelling to high-risk countries.
Influenza segment accounted for a significant revenue in 2020. Influenza vaccines are seasonal flu shot that protects against the 3–4 types of influenza viruses such as viral respiratory illness that spreads quite easily. The flu can lead to serious health complications and even death. CDC recommends a yearly influenza vaccine for people six months and older. Pregnant women should also get the vaccine during each pregnancy.
Vaccine market in North America accounted for the largest revenue share in 2020 due to the presence of major key players investing in R&D activities, growing awareness, and subsequent demand for vaccines in the region. High level of investment in COVID-19 vaccine from the region has contributed to the growth of the market significantly. Adequate policies for immunization of various diseases in the region is also driving market growth.
Some major players in the market include Pfizer, Inc., CSL Limited, Merck & Co., Inc., AstraZeneca, Johnson & Johnson, Serum Institute of India Pvt., Ltd., GlaxoSmithKline PLC, Sanofi Pasteur SA, Emergent Biosolutions, Inc., and Biological E.
The report further divides the Vaccine market into key segments such as types, applications, end-user industries, technologies, and key regions of the market. The report also sheds light on the segment and region exhibiting promising growth in the Vaccine market.

Vaccine Market Segmentation

Type Outlook (Revenue, USD Billion; 2018-2028)

Monovalent Vaccines
Multivalent Vaccines
Patient Type Outlook (Revenue, USD Billion; 2018-2028)

Pediatric Patients
Adult Patients
Application

Technology Outlook (Revenue, USD Billion; 2018-2028)

Inactivated & Subunit Vaccines
Conjugate Vaccines
Recombinant Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Disease Outlook (Revenue, USD Billion; 2018-2028)

DTP
HPV
Pneumococcal Disease
Meningococcal Disease
Influenza
Hepatitis
Varicella
MMR
Polio
Herpes Zoster
Rotavirus
Others
Route of Administration Outlook (Revenue, USD Billion; 2018-2028)

Oral Administration
Intramuscular and Subcutaneous Administration
Others
Regional Segmentation

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request a discount on the report @

Key Questions Answered by the Report:

Which region is expected to dominate the market in the coming years?

What are the recent technological and product advancements occurring in the market?

What are the key strategies adopted by the prominent players in the Vaccine market?

What are the key product types and applications of the Vaccine industry?

What is the outcome of SWOT analysis and Porter’s Five Forces analysis?

How is the competitive landscape of the Vaccine market?

Who are the key players in the industry?

What is the growth rate of the industry over the coming years?

What will be the valuation of the Vaccine Market by 2028?

Request customization of the report @

Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.

Read Latest Articles of Emergen Research :

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Press Release Available @ https://www.emergenresearch.com/press-release/global-vaccine-market

Eric Lee
Emergen Research
+91 90210 91709
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn



Article originally published at https://www.einpresswire.com/article/577107698/vaccine-market-size-worth-usd-77-90-billion-in-2028-advancements-in-technology

This news story originally appeared at Health - Trend Magazine on20 June 2022